Dynavax Technologies | DVAX - سهم



سهم تغيير تاريخ
AbbVie USD 4.95B 13M 2025-12
Adma Biologics USD 206.46M 9.8M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
TG Therapeutics USD 125.59M 21.37M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12